Home › Malattie polmonari interstiziali › Michigan › Ann Arbor
Studi clinici su Malattie polmonari interstiziali a Ann Arbor, MI
11 studi su Malattie polmonari interstiziali cercano partecipanti presso sedi a Ann Arbor e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
In reclutamentoFase 3
- University of Michigan, Ann Arbor
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
In reclutamentoFase 3
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
In reclutamentoFase 2/3
- GSK Investigational Site, Ann Arbor
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
In reclutamento
- University of Michigan - Michigan Medicine, Ann Arbor
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
In reclutamentoFase 2
- Clinical Research Site, Ann Arbor
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
In reclutamentoStudio osservazionale
- University of Michigan, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
In reclutamentoFase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
In reclutamentoFase 2/3
- University of Michigan, Ann Arbor
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
In reclutamentoFase 2
- University of Michigan, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
In reclutamentoFase 2
- Galderma Investigational Site # 8743, Ann Arbor
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
In reclutamentoStudio osservazionale
- University of Michigan, Ann Arbor
Studi su Malattie polmonari interstiziali in altre città
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Charleston, SC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Aurora, CO11 studi
- Phoenix, AZ9 studi
- Salt Lake City, UT9 studi
- Boston, MA9 studi
Altri studi a Ann Arbor
- Cancro alla prostata27 studi
- Cancro al seno26 studi
- Cancro del polmone non a piccole cellule26 studi
- Cancro (tutti i tipi)25 studi
- Cancro colorettale23 studi
- Cancro ai polmoni23 studi
- Insufficienza cardiaca22 studi
- Leucemia mieloide acuta17 studi
- Malattie cardiovascolari16 studi
- Cancro pancreatico14 studi
- Melanoma12 studi
- Cancro al rene (carcinoma a cellule renali)12 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.